Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer

Clinical trial NCT02796898 · COMPLETED

Trial details

NCT number: NCT02796898
Sponsor: Tyme, Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Rising Prostate Specific Antigen (PSA)

Start date: 2016-06-01
Primary completion: 2019-05-30
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.